ZTS FY 2022 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$8.1B+3.9% YoY

Gross Profit

$5.5B67.8% margin

Operating Income

$2.9B36.2% margin

Net Income

$2.1B26.2% margin

EPS (Diluted)

$4.49

Cash Flow

Operating Cash Flow

$1.9B

Free Cash Flow

$1.3B

Stock-Based Comp.

$62M

Balance Sheet

Total Assets

$14.9B

Total Liabilities

$10.5B

Stockholders' Equity

$4.4B

Cash & Equivalents

$3.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.1B	$7.8B	+3.9%
Gross Profit	$5.5B	$5.3B	+3.1%
Operating Income	$2.9B	$2.8B	+4.5%
Net Income	$2.1B	$2.0B	+3.8%